Product Information
- HMS 5552
Dorzagliatin is a new drug for the treatment of type 2 diabetes. It has been shown to be effective in diabetic patients, with a long-term efficacy and pharmacokinetic properties. Dorzagliatin has also been shown to have a pharmacological effect on β-cells, which are cells that produce insulin in the pancreas. This drug's activity is due to its ability to inhibit the production of growth factors and plasma concentration-time curve. In addition, dorzagliatin does not have any enantiomeric isomers and can be detected in blood plasma within one hour after administration.
Chemical properties
Technical inquiry about: 3D-BD167920 Dorzagliatin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
